Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Indomethacin dose-interruption and maternal...
Journal article

Indomethacin dose-interruption and maternal chorioamnionitis are risk factors for indomethacin treatment failure in preterm infants with patent ductus arteriosus

Authors

Wahab MA; Mitra S

Journal

Journal of Clinical Neonatology, Vol. 4, No. 4,

Publisher

Wolters Kluwer

Publication Date

2015

DOI

10.4103/2249-4847.165688

ISSN

2249-4847

Labels

Sustainable Development Goals (SDG)